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PS166.
ABO Blood Type is not Associated with Outcome after
Vascular Surgery
Koen M. van de Luijtgaarden, Erik J. Bakker, Sanne E.
Hoeks, Michiel T. Voute, Yvette R. van Gestel, Hence J.
Verhagen, Don Poldermans. Vascular Surgery, Erasmus
MC, Rotterdam, Netherlands
Objectives: Non-O blood types are associated with
higher levels of von Willebrand factor and factor VIII
and with increased risk of coronary, cerebral and periph-
eral arterial disease and venous thromboembolism. We
hypothesize that non-O blood type is a predictor of
long-term mortality after vascular surgery, although this
effect might be diminished by aspirin and/or Vitamin K
Antagonist use.
Methods: In 3255 major vascular surgery patients,
baseline characteristics, ABO blood type and follow-up
(mean 5 years) were obtained. The primary endpoint was
all-cause mortality, the secondary endpoint was Major Ad-
verse Cardiac Event (MACE). Multivariate analyses, cor-
recting for gender, medical history, left ventricular dysfunc-
tion and smoking, were used to evaluate the impact of ABO
blood type on mortality.
Results: Cardiovascular risk factors, medication and
type of surgery were well balanced between groups. All
patients were on chronic ASA/VKA therapy. Within 30 (ays after surgery, 3.4% of non-O and 3.6% of O patients
uffered MACE (OR 0.94; 95%CI 0.65-1.37). In a multi-
ariate model, O blood type was not associated with in-
reased mortality during long-term follow-up (HR 0.98;
5%CI 0.89-1.09).
Conclusions:Although associated with atherothrombo-
is and increased mortality in CAD, non-O blood type is not
ssociated with either short or long-termmortality in vascular
urgery patients. This discrepancy might be explained by the
igh rate of ASA/VKA use in our population.
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S168.
o Ethnic Differences and TASC Distribution Affect
he Incidence of Lower Extremity Amputation?
icholas J. Gargiulo1, David J. O’Connor2, William D.
uggs1, Larry A. Scher1, Omer Riaz1, Ashish Raju1, Yana
tkin1, Evan C. Lipsitz1. 1Department of Cardiovascular and
horacic Surgery, Albert Einstein College of Medicine and
ontefiore Medical Center, New York, NY; 2Mount Sinai
chool of Medicine, New York, NY
Objectives: There has been recent interest in ethnic
ifferences with a wide variety of disease entities. This
tudy was initiated to better determine what if any factors
ffected a diverse ethnic population afflicted with CLI.
Methods: We reviewed all patients presenting with
LI from January 1, 2007 to December 31, 2007. All
atients underwent conventional arteriography and if pos-
ible an endovascular, open or hybrid procedure for suc-
essful limb salvage. Multivariate logistic regression was
hen used to determine any association between ethnic
ackground and Rutherford Class, co-morbid conditions,
ransAtlantic InterSociety Consensus II (TASC II) classi-
cation, runoff score, types of intervention (open, endovas-
ular or hybrid), prior and repeat procedures, mortality and
ne-year amputation free survival (outcome).
Results: One hundred and forty eight patients pre-
ented with primary, secondary or tertiary CLI over this
ne year period. Of these, 58 (40% ) were Black,
7 (40%) were Latino and 28 (20%) were White. There
as no difference in clinical presentation among the
hree races (P 0.02). All groups had similar rates of
ASC II D iliac disease, however Blacks had a higher
revalence of TASC II D femoropopliteal disease
P0.02). Latinos and Caucasians had a higher preva-
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Primary patency rates among the three ethnic groups
remained similar at 1 year, however the Latino group
displayed poorer patency after one year compared to
Blacks and Caucasians (P0.02). All three ethnic groups
had a similar one year amputation rate of 6.4%.
Conclusions: There does not appear to be a signifi-
cant difference among racial groups in clinical presenta-
tion. There are disparate lesion distributions among the
three ethnic groups, with more severe TASC II D infr-
apopliteal disease in the Latino group, possibly affecting
primary patency rates. There was no clear ethnic differ-
ence amongst the groups with regards to overall ampu-
tation rate.
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disclose; D. J. O’Connor: Nothing to disclose; A. Raju:
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Inadvertent Great Vessel Arterial Catheterization Dur-
ing Ultrasound-Guided Central Venous Line Place-
ment: A Potentially Fatal Event
Lakshmikumar Pillai, Pamela M. Zimmerman, Alexandre
C. d’ Audiffret. Surgery, West Virginia University Medical
Center, Morgantown, WV
Objectives: To review the incidence, efficacy of treat-
ment, and outcome of inadvertent subclavian and carotid
artery catheterization (arterial catheter placement, not sim-
ple cannulation by entry needle) during central venous
access procedures which required open vascular and/or
endovascular repair.
Methods: 5-year retrospective review of all central
venous access procedures performed at a teaching hospital.
Results: From 2005-10 a total of 10,731 central ve-
nous access procedures (“line placements”) were per-
formed. There were 132 (1%) pneumo and or hemo/
pneumothoarcies related to line placement. In 8 patients
there was inadvertent/unrecognized subclavian or carotid
artery catheterization requiring open and/or endovascular
repair. All 8 procedures were done under “ultrasound
guidance” by either Anesthesia or Critical Care Physicians
attempting jugular line placement in the OR or ICU.
Eighty-eight percent(7/8)vessels were successfully re-
paired.5/7 vessels(71%)were repaired using endovascular
methods and 2/7 vessels(29%)using open surgery. The
remaining injured vessel did not require repair due to
successful treatment of hemothorax with chest tube result-
ing in hemostasis at site of vessel injury. However,38%
(3/8) patients still subsequently expired including the lone
patient whose vessel did not require repair- the other two teaths occured in the patients who had undergone open
epair. All deaths were related to the intial injury. The right
ubclavian or carotid artery was the “fatal” vessel catheter-
zed in the deceased patients.
Conclusions: Though rare, inadvertent great vessel
atheterization during central line placement appears to
e a highly morbid and fatal event in 38% of the patients
n this study. Endovascular repair of these injuries ap-
ears to be better tolerated. Although ultrasound guid-
nce is the preferred method of jugular venous imaging
uring central vein catheterization, in this review it did
ot prevent inadvertent arterial catheterization and may
ndeed have imparted a false sense of security.
uthor Disclosures: A. C. d’ Audiffret: Nothing to
isclose; L. Pillai: Nothing to disclose; P. M. Zimmer-
an: Nothing to disclose
S172.
ngiotensin Receptor Blockers, Beta Blockers, and An-
iplatelet Agents Improve Primary Patency after Arte-
io-Venous Hemodialysis Access Placement
ubie S. Maybury1, Anton N. Sidawy2, Richard Amdur1,
obyn A. Macsata1. 1Veterans Affairs Medical Center,
ashington, DC; 2George Washington University Hospi-
al, Washington, DC
Objectives: Arterio-venous hemodialysis access
HDA) failure is a major cause of morbidity in end stage
enal disease. We examined the influence of medications on
DA primary patency (PP).
Methods: After IRB approval, we retrospectively ana-
yzed upper extremity HDA, excluding revisions, placed
rom 2005-2009 at the Washington, DC VAMedical Cen-
er. We used Cox proportional hazard models, adjusted for
atient and access characteristics, to assess the influence of
1 medication classes on PP.
Results: From 261 autogenous and 123 prosthetic
DA, we excluded 6 for unknown thrombosis date and
5 autogenous accesses for primary nonfunctionality.
e analyzed 213 autogenous and 120 prosthetic HDA.
wo yr PP rates were 49% for autogenous vs. 30% for
rosthetic HDA. On multivariable analysis, angiotensin
eceptor blockers (ARBs) and beta-blockers (BBs) re-
uced the risk of autogenous HDA failure, and ARBs
owered the risk of prosthetic HDA failure (Table). On
ubgroup analysis, ARBs prolonged autogenous HDA
atency only among patients using antiplatelet agents
HR 0.21, 95% CI 0.05 - 0.89, p 0.034), indicating that
oth drugs must be used in combination for either to be
ffective. For prosthetic HDA, there were no significant
rug-drug interactions. Model diagnostics showed low
ulticollinearity.
Conclusions:After HDA placement, administration of
RB plus an antiplatelet agent or BB (for autogenous
DA) or ARB (for prosthetic HDA) should be consideredo improve patency.
